PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 273 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 3.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $24 | -100.0% | 637 | -30.4% | 0.00% | – |
| Q3 2022 | $48,000 | -21.3% | 915 | -14.0% | 0.00% | – |
| Q2 2022 | $61,000 | -18.7% | 1,064 | +8.2% | 0.00% | – |
| Q1 2022 | $75,000 | +29.3% | 983 | +0.7% | 0.00% | – |
| Q4 2021 | $58,000 | -10.8% | 976 | -16.2% | 0.00% | – |
| Q3 2021 | $65,000 | -4.4% | 1,165 | +2.8% | 0.00% | – |
| Q2 2021 | $68,000 | -6.8% | 1,133 | +7.9% | 0.00% | – |
| Q1 2021 | $73,000 | +17.7% | 1,050 | +1.3% | 0.00% | – |
| Q4 2020 | $62,000 | +14.8% | 1,037 | +14.7% | 0.00% | -100.0% |
| Q3 2020 | $54,000 | +237.5% | 904 | +200.3% | 0.00% | – |
| Q2 2020 | $16,000 | +33.3% | 301 | -17.1% | 0.00% | – |
| Q1 2020 | $12,000 | +33.3% | 363 | +81.5% | 0.00% | – |
| Q4 2019 | $9,000 | +12.5% | 200 | 0.0% | 0.00% | – |
| Q3 2019 | $8,000 | +33.3% | 200 | +22.7% | 0.00% | – |
| Q1 2019 | $6,000 | – | 163 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
| Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
| GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
| DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
| NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
| Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
| Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |